|
MYO9A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.833040E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.402300E-04 |
| Normal-vs-Stage2 |
3.183200E-03 |
| Normal-vs-Stage3 |
2.761800E-02 |
| Normal-vs-Stage4 |
1.259390E-03 |
| Stage1-vs-Stage2 |
7.070800E-01 |
| Stage1-vs-Stage3 |
7.371400E-01 |
| Stage1-vs-Stage4 |
4.652800E-01 |
| Stage2-vs-Stage3 |
9.704800E-01 |
| Stage2-vs-Stage4 |
4.830000E-01 |
| Stage3-vs-Stage4 |
6.456200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.553600E-04 |
| Normal-vs-AfricanAmerican |
5.215000E-04 |
| Normal-vs-Asian |
1.571750E-04 |
| Caucasian-vs-AfricanAmerican |
4.357800E-01 |
| Caucasian-vs-Asian |
1.503920E-03 |
| AfricanAmerican-vs-Asian |
7.038800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.73929999999212E-05 |
| Normal-vs-Female |
2.370600E-01 |
| Male-vs-Female |
3.114500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.862100E-03 |
| Normal-vs-Extreme_Weight |
5.173200E-04 |
| Normal-vs-Obese |
1.357610E-02 |
| Normal-vs-Extreme_Obese |
6.764200E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.902600E-01 |
| Normal_Weight-vs-Obese |
6.098400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.848000E-01 |
| Extreme_Weight-vs-Obese |
3.137200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.008400E-01 |
| Obese-vs-Extreme_Obese |
2.817400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.437400E-04 |
| Normal-vs-Age(41-60Yrs) |
1.319990E-01 |
| Normal-vs-Age(61-80Yrs) |
7.41000000026304E-07 |
| Normal-vs-Age(81-100Yrs) |
2.039800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.132300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.848200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.503200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.875200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.305600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.461000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.637200E-03 |
| Normal-VS-Type2 PRCC |
1.19200000003872E-06 |
| Normal-VS-KIRP CIMP |
3.553800E-04 |
| Normal-VS-Unclassified PRCC |
4.143000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.584150E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.521900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.312000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.825000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.653700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.022300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.80959979912654E-10 |
| Normal-vs-N1 |
1.956200E-03 |
| Normal-vs-N2 |
4.876700E-03 |
| N0-vs-N1 |
3.350200E-01 |
| N0-vs-N2 |
6.457000E-01 |
| N1-vs-N2 |
5.023800E-01 |
|
|
